United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nordic pharma ltd - hydroxycarbamide - tablet - 100mg

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; magnesium stearate; titanium dioxide; gelatin; indigo carmine; lactose monohydrate; quinoline yellow; dibasic sodium phosphate; citric acid; sodium lauryl sulfate - significant tumour response to hydroxycarbamide (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - hydroxycarbamide - oral solution - 100mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - hydroxycarbamide - oral capsule - 300mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - hydroxycarbamide - oral capsule - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - hydroxycarbamide - oral capsule - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - hydroxycarbamide - oral suspension - 100mg/1ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medac gmbh - hydroxycarbamide - capsules - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - hydroxycarbamide - oral capsule - 500mg

European Union - English - EMA (European Medicines Agency)

theravia - hydroxycarbamide - anemia, sickle cell - antineoplastic agents - siklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in paediatric and adult patients suffering from symptomatic sickle-cell syndrome.